|
SMC6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.495500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.139960E-01 |
| Normal-vs-Stage2 |
3.648600E-01 |
| Normal-vs-Stage3 |
7.785600E-02 |
| Normal-vs-Stage4 |
4.541800E-01 |
| Stage1-vs-Stage2 |
7.421400E-01 |
| Stage1-vs-Stage3 |
3.414000E-01 |
| Stage1-vs-Stage4 |
6.334000E-01 |
| Stage2-vs-Stage3 |
7.301000E-01 |
| Stage2-vs-Stage4 |
7.344200E-01 |
| Stage3-vs-Stage4 |
8.486000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.384100E-02 |
| Normal-vs-AfricanAmerican |
7.744400E-02 |
| Normal-vs-Asian |
1.888020E-01 |
| Caucasian-vs-AfricanAmerican |
9.020800E-01 |
| Caucasian-vs-Asian |
2.244800E-01 |
| AfricanAmerican-vs-Asian |
2.378600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.323800E-02 |
| Normal-vs-Female |
3.790900E-04 |
| Male-vs-Female |
8.755200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.171000E-01 |
| Normal-vs-Extreme_Weight |
7.457600E-01 |
| Normal-vs-Obese |
6.043900E-03 |
| Normal-vs-Extreme_Obese |
4.666200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.631000E-01 |
| Normal_Weight-vs-Obese |
1.268440E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.053200E-01 |
| Extreme_Weight-vs-Obese |
1.327850E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.066200E-01 |
| Obese-vs-Extreme_Obese |
4.991400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.023900E-03 |
| Normal-vs-Age(41-60Yrs) |
8.610700E-04 |
| Normal-vs-Age(61-80Yrs) |
4.004000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.807200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.861100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.956200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.899990E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.783000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.264000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.856800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.283100E-03 |
| Normal-VS-Type2 PRCC |
7.807400E-01 |
| Normal-VS-KIRP CIMP |
4.008200E-02 |
| Normal-VS-Unclassified PRCC |
2.250400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.268610E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.426300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.470200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.175800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.620200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.493620E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.992000E-01 |
| Normal-vs-N1 |
1.377780E-02 |
| Normal-vs-N2 |
9.746800E-01 |
| N0-vs-N1 |
1.571730E-02 |
| N0-vs-N2 |
9.694800E-01 |
| N1-vs-N2 |
3.028800E-01 |
|
|
